AIMOVIG vs WINREVAIR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. AIMOVIG and WINREVAIR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	WINREVAIR
Rating	72/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	SOTATERCEPT-CSRK
Manufacturer	Amgen Inc	Merck Sharp Dohme
Dosage forms	Injectable, Solution	Kit
Drug class	—	—
Boxed warning	None	None
Treats	—	Pulmonary Arterial Hypertension

aimovig winrevair

Rating

72/100

70/100

Pharmacy pays

—

Type

Active ingredient

ERENUMAB-AOOE

SOTATERCEPT-CSRK

Manufacturer

Amgen Inc

Merck Sharp Dohme

Dosage forms

Injectable, Solution

Kit

Drug class

—

Boxed warning

None

Treats

—

Pulmonary Arterial Hypertension

Frequently asked questions

Which is better-rated, Aimovig or Winrevair?

By our independent rating, Aimovig scores higher — 3.6 vs 3.5 out of 5 for Winrevair. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Aimovig and Winrevair?

Aimovig contains Erenumab-Aooe, while Winrevair contains Sotatercept-Csrk — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.